Evidence map›Paper›PMID 39679880›Full record

ReviewJournal of radiation research2024

What can we learn from high background radiation area (HBRA) studies in three Asian countries: India, China and Indonesia? Radiological aspects in various HBRAs.

Chutima Kranrod, Hiromi Kudo, Shinji Tokonami

Abstract readReview
In one paragraph

Review in Journal of radiation research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chutima KranrodInstitute of Radiation Emergency Medicine, Department of International Cooperation and Collaborative Research, Hirosaki University, 66-1 Hon-Cho, Hirosaki, Aomori 036-8564, Japan.
Hiromi KudoGraduate School of Health Sciences, Department of Nursing Science, Hirosaki University, 66-1 Hon-Cho, Hirosaki, Aomori 036-8564, Japan.
Shinji TokonamiInstitute of Radiation Emergency Medicine, Department of International Cooperation and Collaborative Research, Hirosaki University, 66-1 Hon-Cho, Hirosaki, Aomori 036-8564, Japan.

Funding

JSPS KAKENHI JP18KK0261 and JP20H00556
6 · The paper itself

Abstract

Radiation is a pervasive natural phenomenon that has been present on earth since its inception. However, exposure to high background radiation levels can pose significant health risks to individuals living in affected areas. In recent years, several studies have been conducted in high background radiation areas (HBRAs), including high radon concentration areas, to understand the radiological aspects and the lessons learned of radiation exposure. The purpose of this article is to provide a comprehensive review of radiological hazards and lessons learned from studies in high-background radiation areas in some countries of Asia (India, China and Indonesia). In this article, we will explore the hazards associated with radiation exposure from terrestrial radiation and additionally radon inhalation, the different studies conducted in HBRA and the lessons learned from these studies. Ultimately, this article aims to provide a better understanding of the radiological aspects of HBRAs and to identify the key lessons learned from previous studies to prevent future health risks. Likewise, research conducted in different high-background radiation areas in some countries of Asia has provided valuable insights into the radiological aspects of these areas and their potential impact on human health.

Indexed as

Background RadiationRadonChinaHumansIndiaIndonesiaRadondose assessmenthealth risk assessmenthigh background radiation area (HBRA)

Identifiers

PMID39679880
PMCPMC11647924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.